Chronic urticaria lasts an average of about 11 years, though individual experiences vary enormously. Some people see their hives resolve within a year, while others deal with flare-ups for decades. The condition is defined by recurring hives, swelling, or both that persist for six weeks or longer, distinguishing it from acute urticaria, which clears up faster.
The good news is that chronic urticaria is considered self-limiting, meaning it does eventually resolve on its own for most people. But “eventually” can feel like a long time when you’re living with itchy, unpredictable welts.
Remission Rates at 1, 5, and 20 Years
A targeted review of the medical literature found that roughly 17% of people with chronic spontaneous urticaria achieve remission within the first year. By the five-year mark, that number climbs to about 45%. And by 20 years, approximately 73% of patients have experienced remission. Individual studies show a wide range: first-year remission rates vary from 21% to 47% depending on the population studied, and five-year rates range from 29% to 71%.
These numbers reflect a few realities. Milder cases tend to resolve sooner, pulling the early remission rates up. More severe or treatment-resistant cases drag on for years, which is why the overall average disease duration sits around 11 years. If you’re in your first year or two, there’s a reasonable chance your hives will resolve relatively soon. But if they’ve already lasted several years, the timeline becomes harder to predict.
What Makes It Last Longer
Certain patterns are associated with a longer disease course. The presence of angioedema (deeper swelling beneath the skin, often around the eyes or lips) alongside hives tends to signal a more persistent condition. Thyroid antibodies, found in up to 33% of people with chronic spontaneous urticaria, are also linked to longer duration. If your doctor has tested for these and found them, that doesn’t mean your urticaria is untreatable, but it may take longer to fully resolve.
Severity itself can be a predictor. People with more intense flares and higher levels of certain inflammatory markers tend to have longer courses and may respond less readily to standard antihistamine therapy. Your doctor may use blood tests not just to rule out other conditions but to get a rough sense of how your immune system is behaving and what treatment approach is most likely to help.
Children Tend to Recover Faster
In children, chronic urticaria typically follows a shorter and milder course. A study comparing pediatric and adult patients found that the median disease duration in children was about 5 months, compared to 12 months in adults. Children are also less likely to develop angioedema alongside their hives and tend to respond better to antihistamines. As patients move into adolescence and adulthood, the condition generally becomes more severe and harder to manage.
Inducible Urticaria Can Last Longer
Chronic urticaria comes in two main forms. The spontaneous type produces hives without any obvious external trigger. The inducible type flares in response to specific physical stimuli like cold temperatures, pressure on the skin, sweating, or sunlight. People often assume inducible urticaria is less serious because the trigger is identifiable, but it actually tends to last longer.
Cold-triggered urticaria has a median duration of about 24 months before patients even seek specialist care, compared to roughly 6 months for spontaneous urticaria. Pressure-triggered and sweat-triggered forms show similar patterns, with median durations of 24 and 21 months respectively. Part of this is likely because people with identifiable triggers feel they can manage the condition by avoidance, delaying specialist referral. But the underlying disease process can persist for years regardless.
Treatment Controls Symptoms but May Not Shorten the Course
Standard treatment with antihistamines and, for more resistant cases, targeted injections that block a key immune signaling molecule can dramatically reduce or eliminate hives. But there’s an important distinction between symptom control and disease resolution. Current treatments suppress the immune activity driving your hives. They don’t appear to speed up the underlying process that eventually leads to natural remission.
This becomes clear when looking at what happens after treatment stops. In one study of 200 patients who discontinued their injectable therapy, 50% relapsed within a median of four months. Among those who stopped treatment abruptly, the relapse rate was 65%. Patients whose doses were gradually tapered fared much better, with only about 16% relapsing. The average time to a first relapse after stopping treatment was about 74 weeks, or roughly a year and a half.
This doesn’t mean treatment is pointless. Controlling symptoms for months or years while the disease runs its course makes an enormous difference in quality of life. And for some people, the disease does burn out during treatment, so that when they stop, the hives simply don’t return. The challenge is that there’s no reliable way to know whether you’re in that group until you try tapering off.
What Remission Actually Looks Like
Remission in chronic urticaria means a sustained period without hives or angioedema while off all treatment. For many people, this doesn’t arrive as a clean on/off switch. The condition often waxes and wanes, with stretches of weeks or months where symptoms are minimal, followed by unexpected flares. Over time, the flares tend to become less frequent and less intense before eventually stopping altogether.
Some people experience what feels like complete remission only to have symptoms return months or even years later. This is not uncommon and doesn’t necessarily mean you’re back to square one. Recurrences after a period of remission can be shorter and milder than the original course.
If your chronic urticaria has lasted several years and feels like it will never end, the statistics offer some reassurance: the vast majority of people do eventually reach lasting remission. The timeline is frustratingly unpredictable, but the overall trajectory points toward resolution rather than permanence.